AI assistant
Sending…
BIOGEN INC. — Director's Dealing 2017
Dec 5, 2017
30291_dirs_2017-12-05_1ad1dbee-5895-488d-aa4f-bfd8b23c8c76.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2017-12-01
Reporting Person: COVINO GREGORY F (VP, Chief Accounting Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-12-01 | Common Stock | F | 54 | $319.35 | Disposed | 4542.3601 | Direct |
| 2017-12-01 | Common Stock | F | 103 | $319.35 | Disposed | 4439.3601 | Direct |
Footnotes
F1: Includes 86.155 shares and 5.382 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2017 and 6/30/2017, respectively.
More from BIOGEN INC.
Regulatory Filings
2026
May 14
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Major Shareholding Notification
2026
Apr 7
Regulatory Filings
2026
Apr 6